210 related articles for article (PubMed ID: 24939846)
1. Targeting the ion channel Kv1.3 with scorpion venom peptides engineered for potency, selectivity, and half-life.
Edwards W; Fung-Leung WP; Huang C; Chi E; Wu N; Liu Y; Maher MP; Bonesteel R; Connor J; Fellows R; Garcia E; Lee J; Lu L; Ngo K; Scott B; Zhou H; Swanson RV; Wickenden AD
J Biol Chem; 2014 Aug; 289(33):22704-22714. PubMed ID: 24939846
[TBL] [Abstract][Full Text] [Related]
2. A designer ligand specific for Kv1.3 channels from a scorpion neurotoxin-based library.
Takacs Z; Toups M; Kollewe A; Johnson E; Cuello LG; Driessens G; Biancalana M; Koide A; Ponte CG; Perozo E; Gajewski TF; Suarez-Kurtz G; Koide S; Goldstein SA
Proc Natl Acad Sci U S A; 2009 Dec; 106(52):22211-6. PubMed ID: 20007782
[TBL] [Abstract][Full Text] [Related]
3. Prolonged immunomodulation in inflammatory arthritis using the selective Kv1.3 channel blocker HsTX1[R14A] and its PEGylated analog.
Tanner MR; Tajhya RB; Huq R; Gehrmann EJ; Rodarte KE; Atik MA; Norton RS; Pennington MW; Beeton C
Clin Immunol; 2017 Jul; 180():45-57. PubMed ID: 28389388
[TBL] [Abstract][Full Text] [Related]
4. Discovery of three toxin peptides with Kv1.3 channel and IL-2 cytokine-inhibiting activities from Non-Buthidae scorpions, Chaerilus tricostatus and Chaerilus tryznai.
Ding L; Chen J; Hao J; Zhang J; Huang X; Hu F; Wu Z; Liu Y; Li W; Cao Z; Wu Y; Li J; Li S; Liu H; Wu W; Chen Z
Peptides; 2017 May; 91():13-19. PubMed ID: 28300672
[TBL] [Abstract][Full Text] [Related]
5. A new Kaliotoxin selective towards Kv1.3 and Kv1.2 but not Kv1.1 channels expressed in oocytes.
Abbas N; Belghazi M; Abdel-Mottaleb Y; Tytgat J; Bougis PE; Martin-Eauclaire MF
Biochem Biophys Res Commun; 2008 Nov; 376(3):525-30. PubMed ID: 18804453
[TBL] [Abstract][Full Text] [Related]
6. Genomic and structural characterization of Kunitz-type peptide LmKTT-1a highlights diversity and evolution of scorpion potassium channel toxins.
Chen Z; Luo F; Feng J; Yang W; Zeng D; Zhao R; Cao Z; Liu M; Li W; Jiang L; Wu Y
PLoS One; 2013; 8(4):e60201. PubMed ID: 23573241
[TBL] [Abstract][Full Text] [Related]
7. The Kv1.3 K
Varga Z; Tajti G; Panyi G
Biol Futur; 2021 Mar; 72(1):75-83. PubMed ID: 34554500
[TBL] [Abstract][Full Text] [Related]
8. Structural basis of a potent peptide inhibitor designed for Kv1.3 channel, a therapeutic target of autoimmune disease.
Han S; Yi H; Yin SJ; Chen ZY; Liu H; Cao ZJ; Wu YL; Li WX
J Biol Chem; 2008 Jul; 283(27):19058-65. PubMed ID: 18480054
[TBL] [Abstract][Full Text] [Related]
9. Functional role of Kv1.1 and Kv1.3 channels in the neoplastic progression steps of three cancer cell lines, elucidated by scorpion peptides.
Aissaoui D; Mlayah-Bellalouna S; Jebali J; Abdelkafi-Koubaa Z; Souid S; Moslah W; Othman H; Luis J; ElAyeb M; Marrakchi N; Essafi-Benkhadir K; Srairi-Abid N
Int J Biol Macromol; 2018 May; 111():1146-1155. PubMed ID: 29415410
[TBL] [Abstract][Full Text] [Related]
10. sVmKTx, a transcriptome analysis-based synthetic peptide analogue of Vm24, inhibits Kv1.3 channels of human T cells with improved selectivity.
Csoti A; Del Carmen Nájera Meza R; Bogár F; Tajti G; Szanto TG; Varga Z; Gurrola GB; Tóth GK; Possani LD; Panyi G
Biochem Pharmacol; 2022 May; 199():115023. PubMed ID: 35358481
[TBL] [Abstract][Full Text] [Related]
11. The Scorpion Toxin Analogue BmKTX-D33H as a Potential Kv1.3 Channel-Selective Immunomodulator for Autoimmune Diseases.
Ye F; Hu Y; Yu W; Xie Z; Hu J; Cao Z; Li W; Wu Y
Toxins (Basel); 2016 Apr; 8(4):115. PubMed ID: 27104568
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms Underlying the Inhibition of KV1.3 Channel by Scorpion Toxin ImKTX58.
Zhang X; Zhao Q; Yang F; Lan Z; Li Y; Xiao M; Yu H; Li Z; Zhou Y; Wu Y; Cao Z; Yin S
Mol Pharmacol; 2022 Sep; 102(3):150-160. PubMed ID: 35764383
[TBL] [Abstract][Full Text] [Related]
13. Vm24, a natural immunosuppressive peptide, potently and selectively blocks Kv1.3 potassium channels of human T cells.
Varga Z; Gurrola-Briones G; Papp F; Rodríguez de la Vega RC; Pedraza-Alva G; Tajhya RB; Gaspar R; Cardenas L; Rosenstein Y; Beeton C; Possani LD; Panyi G
Mol Pharmacol; 2012 Sep; 82(3):372-82. PubMed ID: 22622363
[TBL] [Abstract][Full Text] [Related]
14. Autocrine-Based Selection of Drugs That Target Ion Channels from Combinatorial Venom Peptide Libraries.
Zhang H; Du M; Xie J; Liu X; Sun J; Wang W; Xin X; Possani LD; Yea K; Lerner RA
Angew Chem Int Ed Engl; 2016 Aug; 55(32):9306-10. PubMed ID: 27197631
[TBL] [Abstract][Full Text] [Related]
15. Peptide blockers of K
Chandy KG; Norton RS
Curr Opin Chem Biol; 2017 Jun; 38():97-107. PubMed ID: 28412597
[TBL] [Abstract][Full Text] [Related]
16. Structure, function, and chemical synthesis of Vaejovis mexicanus peptide 24: a novel potent blocker of Kv1.3 potassium channels of human T lymphocytes.
Gurrola GB; Hernández-López RA; Rodríguez de la Vega RC; Varga Z; Batista CV; Salas-Castillo SP; Panyi G; del Río-Portilla F; Possani LD
Biochemistry; 2012 May; 51(19):4049-61. PubMed ID: 22540187
[TBL] [Abstract][Full Text] [Related]
17. The voltage-gated potassium channel K
Tajti G; Wai DCC; Panyi G; Norton RS
Biochem Pharmacol; 2020 Nov; 181():114146. PubMed ID: 32653588
[TBL] [Abstract][Full Text] [Related]
18. ImKTx96, a peptide blocker of the Kv1.2 ion channel from the venom of the scorpion Isometrus maculates.
Li S; Sunchen S; He D; Qin C; Zuo Z; Shen B; Cao Z; Hong W; Miao L
Peptides; 2020 Jan; 123():170172. PubMed ID: 31626826
[TBL] [Abstract][Full Text] [Related]
19. K
Veytia-Bucheli JI; Jiménez-Vargas JM; Melchy-Pérez EI; Sandoval-Hernández MA; Possani LD; Rosenstein Y
Cell Commun Signal; 2018 Aug; 16(1):45. PubMed ID: 30107837
[TBL] [Abstract][Full Text] [Related]
20. ImKTx1, a new Kv1.3 channel blocker with a unique primary structure.
Chen Z; Hu Y; Han S; Yin S; He Y; Wu Y; Cao Z; Li W
J Biochem Mol Toxicol; 2011; 25(4):244-51. PubMed ID: 21308893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
